FDA approves first oral blood-thinning medication for children
Adults' worries have been assuaged with the knowledge that there are medicines out there to deal with side effects, after it become known that risks of the (Pfizer) jab are blood clots and cardiomyopathy. Luckily, Pfizer also makes Eliquis for treating blood clots – sales up 13%. They also make Vyndaqel to treat cardiomyopathy – sales up 77%. The only worry about cardiomyopathy might be that scarring damage is permanent and can't be easily cured with a pill - or is that myocarditis? I'll stand corrected on this latter sentence.
I'm sad for children and teens who've really suffered in visible and invisible ways over the last two years of truncated lives. And in the developing world, their trauma goes beyond gaining weight and loneliness, they've been plunged into ever-deeper poverty-stricken households living on the smell of a chip-wrapper, along with their parents.
Just two of many disturbing news items about children:
--- In the UK, there has been a more than 50% increase in the number of children going to A&E with serious mental health problems since the beginning of lockdowns and almost 30,000 are being prescribed antidepressants each month;
--- New USA CDC Study on kids staying at home, not participating in sport, stress-eating: "the portion of 5-11-year-olds who are classified as overweight or obese is now 45.7 percent, up from 36.2 percent before the pandemic."
In other news, the FDA Panel rejected Pfizer Boosters (16-2 vote), except for the over-65s.
Pfizer has already made $19 Billion in the second quarter this year, or $211 million per day, so this news isn't a blow.
We can only presume they've bounced back from 2009 when they were sued $2,300,000,000 for 'bribing doctors and suppressing adverse trial results.'